PTK2 and breast cancer: Extracellular CTGF directly binds integrin αvβ3 and activates the FAK/Src/NF-κB p65 signaling axis, leading to the upregulation of Glut3 transcription, through which the glycolytic and migratory capacities of breast cancer cells are enhanced (Kim et al., 2021).